Literature DB >> 20581319

Nutrition in hepatic encephalopathy.

Rajagopal Chadalavada1, Raja Shekhar Sappati Biyyani, John Maxwell, Kevin Mullen.   

Abstract

Protein calorie malnutrition (PCM) is a well-known complication of chronic liver disease (CLD). A major contribution to PCM in CLD is restriction of dietary protein intake. After many decades of injudicious reduction in dietary protein, cirrhotic patients are now prescribed appropriate amounts of protein. PCM in CLD is known to be associated with life-threatening complications. In the general approach to these patients, the initial and most important step for the clinician is to recognize the extent of malnutrition. Most patients tolerate a normal amount of dietary protein without developing hepatic encephalopathy (HE). Oral branched-chain amino acids (BCAAs) have a limited role in HE. Patients who exhibit dietary protein intolerance originally were thought to be best treated with BCAA formulations. Mixed evidence has been reported in multiple studies. In keeping with other reports, this article shows that in animal protein-intolerant patients, even those with advanced cirrhosis, vegetable protein-based diets are well tolerated. Another approach to management of apparent dietary intolerance is to optimize HE treatment with available medications. This article reviews the causes of HE, minimal HE, and PCM; examines nutrition requirements and assessment; and discusses treatment options for malnutrition in HE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581319     DOI: 10.1177/0884533610368712

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  12 in total

1.  Lower values of handgrip strength and adductor pollicis muscle thickness are associated with hepatic encephalopathy manifestations in cirrhotic patients.

Authors:  L Augusti; L C Franzoni; L A A Santos; T B Lima; M V Ietsugu; K H Koga; S M Moriguchi; L E Betting; C A Caramori; G F Silva; F G Romeiro
Journal:  Metab Brain Dis       Date:  2016-04-30       Impact factor: 3.584

2.  Practical Issues in the Management of Overt Hepatic Encephalopathy.

Authors:  Ganesh Pantham; Kevin D Mullen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-11

Review 3.  Appropriate protein and specific amino acid delivery can improve patient outcome: fact or fantasy?

Authors:  Christy M Lawson; Keith R Miller; Vance L Smith; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2011-08

Review 4.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 5.  Nutritional assessment in cirrhotic patients with hepatic encephalopathy.

Authors:  Fernando Gomes Romeiro; Laís Augusti
Journal:  World J Hepatol       Date:  2015-12-28

6.  Management of hepatic encephalopathy by traditional chinese medicine.

Authors:  Chun Yao; Nong Tang; Guoxiang Xie; Xiaojiao Zheng; Ping Liu; Lei Fu; Wu Xie; Fan Yao; Houkai Li; Wei Jia
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-05       Impact factor: 2.629

7.  Protein tolerance to standard and high protein meals in patients with liver cirrhosis.

Authors:  Octavio Campollo; Dirk Sprengers; Gitte Dam; Hendrik Vilstrup; Neil McIntyre
Journal:  World J Hepatol       Date:  2017-05-18

Review 8.  Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.

Authors:  Saleh Elwir; Robert S Rahimi
Journal:  J Clin Transl Hepatol       Date:  2017-05-04

Review 9.  Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions.

Authors:  Duminda Suraweera; Vinay Sundaram; Sammy Saab
Journal:  Gut Liver       Date:  2016-07-15       Impact factor: 4.519

Review 10.  Nutrition in Chronic Liver Disease.

Authors:  Marco Silva; Sara Gomes; Armando Peixoto; Paulo Torres-Ramalho; Hélder Cardoso; Rosa Azevedo; Carla Cunha; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.